Hematopoietic stem cell transplant (HSCT) is a well-known aggressive therapeutic intervention for both the congenital and the malignant disorders of the hematopoietic system. Though the survival rate of HSCT is well established in Pakistan, yet the effectiveness of this treatment and its impact on the quality of life of survivors in the context of Pakistan, remains unexplored. Objective: The aim of the study was to explore the QOL of HSCT survivors in Pakistan. Methodology: This study employed a qualitative descriptive design to explore the quality of life of I-ISCT survivors. The study setting was the bone marrow transplant outpatient clinics in two of the four centres of Pakistan, which included one private tertiary care hospital and one ...
[[abstract]]Hematopoietic stem cell transplantation offers cancer patients hope for a cure. However,...
Haematopoietic stem cell transplantation is a therapeutic method which is not only used for the trea...
Quality of life (QOL) is an important clinical end-point to be considered in the late follow-up of p...
Haematopoietic stem cell transplantation (HSCT) was started in Malaysia since 1993 and it has improv...
Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and fai...
This descriptive study explored the quality of life and care needs of Turkish patients who underwent...
Background: This study explored the state of hematopoietic stem cell transplantation (HSCT) recipien...
Health-related quality of life after stem cell transplantation – The first year Inger Andersson Ins...
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...
AbstractThe number of survivors after allogeneic hematopoietic stem cell transplantation (HSCT) cont...
It is well known that patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)...
Objective: This article reviews recent literature on adults' quality of life following hematopoietic...
Purpose: To evaluate the global quality of life (QoL) of survivors with 10-year or more post-trans-p...
Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic ...
Identifying factors that predict health-related quality of life (QOL) following hematopoietic SCT, i...
[[abstract]]Hematopoietic stem cell transplantation offers cancer patients hope for a cure. However,...
Haematopoietic stem cell transplantation is a therapeutic method which is not only used for the trea...
Quality of life (QOL) is an important clinical end-point to be considered in the late follow-up of p...
Haematopoietic stem cell transplantation (HSCT) was started in Malaysia since 1993 and it has improv...
Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and fai...
This descriptive study explored the quality of life and care needs of Turkish patients who underwent...
Background: This study explored the state of hematopoietic stem cell transplantation (HSCT) recipien...
Health-related quality of life after stem cell transplantation – The first year Inger Andersson Ins...
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...
AbstractThe number of survivors after allogeneic hematopoietic stem cell transplantation (HSCT) cont...
It is well known that patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)...
Objective: This article reviews recent literature on adults' quality of life following hematopoietic...
Purpose: To evaluate the global quality of life (QoL) of survivors with 10-year or more post-trans-p...
Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic ...
Identifying factors that predict health-related quality of life (QOL) following hematopoietic SCT, i...
[[abstract]]Hematopoietic stem cell transplantation offers cancer patients hope for a cure. However,...
Haematopoietic stem cell transplantation is a therapeutic method which is not only used for the trea...
Quality of life (QOL) is an important clinical end-point to be considered in the late follow-up of p...